Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-05

AUTHORS

Allan Zeeberg Iversen, Soeren Galatius, Sune Pedersen, Jan K. Madsen, Jan S. Jensen

ABSTRACT

BACKGROUND: An increasing proportion of patients with acute coronary syndrome (ACS) requiring percutaneous coronary intervention (PCI) are classified as elderly (aged ≥70 years). The glycoprotein IIb/IIIa inhibitor abciximab is known to reduce adverse outcomes in patients aged <70 years with high-risk ACS undergoing PCI, but conflicting findings relating to its effects in the elderly have been reported. OBJECTIVE: The aim of this study was to evaluate the effect of abciximab in elderly high-risk ACS patients undergoing PCI. METHODS: From our dedicated PCI registry we identified 2068 ACS patients with high-risk lesions that were treated with PCI. Baseline data were collected prospectively. All-cause mortality, target vessel revascularization (TVR), myocardial infarction (MI), and the combination of these were primary study endpoints. All endpoints within 1 year after PCI were registered and validated. The population was subsequently stratified according to age and use of abciximab. RESULTS: Elderly patients constituted 42% of the total population. They presented with more co-morbidities, were less frequently treated with abciximab and had a higher risk of reaching the combined endpoint and higher all-cause mortality than younger patients. The age/abciximab stratified analysis revealed no effect of abciximab on any of the endpoints in elderly patients (combined endpoint: no abciximab 22.6% vs abciximab 23.4%, p=0.85; all-cause mortality: no abciximab 15.4% vs abciximab 15.9%, p=0.91; TVR: no abciximab 3.4% vs abciximab 5.5%, p=0.21; MI: no abciximab 7.0% vs abciximab 8.5%, p=0.54), whereas all-cause mortality and the risk of reaching the combined endpoint were significantly reduced in younger patients (combined endpoint: no abciximab 14.0% vs abciximab 9.4%, p=0.03; all-cause mortality: no abciximab 4.5% vs abciximab 1.7%, p=0.02; TVR: no abciximab 5.5% vs abciximab 4.3%, p=0.39; MI: no abciximab 7.2% vs abciximab 6.6%, p=0.80). These findings were confirmed in our adjusted analyses. CONCLUSIONS: In this large observational study we found no benefit of abciximab treatment in elderly high-risk ACS patients who underwent PCI. These findings should be taken into consideration when deciding on the treatment strategy for elderly ACS patients undergoing PCI. More... »

PAGES

369-378

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/11587170-000000000-00000

DOI

http://dx.doi.org/10.2165/11587170-000000000-00000

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1022273563

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21542659


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Coronary Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angioplasty", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endpoint Determination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin Fab Fragments", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Glycoprotein GPIIb-IIIa Complex", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Registries", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Gentofte Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411646.0", 
          "name": [
            "Department of Cardiology P, Gentofte University Hospital, Niels Andersens Vej 65, DK-2900, Hellerup, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iversen", 
        "givenName": "Allan Zeeberg", 
        "id": "sg:person.01114465002.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114465002.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gentofte Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411646.0", 
          "name": [
            "Department of Cardiology P, Gentofte University Hospital, Niels Andersens Vej 65, DK-2900, Hellerup, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Galatius", 
        "givenName": "Soeren", 
        "id": "sg:person.01026574677.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026574677.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gentofte Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411646.0", 
          "name": [
            "Department of Cardiology P, Gentofte University Hospital, Niels Andersens Vej 65, DK-2900, Hellerup, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pedersen", 
        "givenName": "Sune", 
        "id": "sg:person.01212500565.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212500565.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gentofte Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411646.0", 
          "name": [
            "Department of Cardiology P, Gentofte University Hospital, Niels Andersens Vej 65, DK-2900, Hellerup, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Madsen", 
        "givenName": "Jan K.", 
        "id": "sg:person.01007016143.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007016143.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Copenhagen", 
          "id": "https://www.grid.ac/institutes/grid.5254.6", 
          "name": [
            "Department of Cardiology P, Gentofte University Hospital, Niels Andersens Vej 65, DK-2900, Hellerup, Denmark", 
            "Clinical Institute of Surgery and Internal Medicine, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jensen", 
        "givenName": "Jan S.", 
        "id": "sg:person.012431026112.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012431026112.60"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1161/01.cir.78.2.486", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001424008"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cardiores.2004.12.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001812022"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.103.25.3051", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002347157"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.107.182615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003775013"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.106.642306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007883017"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2004.06.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009659065"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ccd.20456", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013928798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ccd.20456", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013928798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2005.06.072", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015979769"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2005.06.072", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015979769"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199706123362401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017752478"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002512-200016030-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026921696", 
          "https://doi.org/10.2165/00002512-200016030-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002512-200016030-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026921696", 
          "https://doi.org/10.2165/00002512-200016030-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehp118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031010310"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0895-4356(02)00591-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033511300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0895-4356(02)00591-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033511300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehi731", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034540833"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000142862.98817.1f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035757918"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijcard.2008.02.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036705033"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2006.07.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038467272"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.295.13.joc60034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039342754"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199404073301402", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040255966"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.hyp.38.2.274", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041862010"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(96)10452-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044275166"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(98)85010-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044923927"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.99.23.2986", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045165937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.286.6.708", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046042299"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1076-7460.2000.80049.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047924281"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.106.685313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052751505"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(98)06113-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054617046"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-141-3-200408030-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073707555"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078321162", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0749-0690(18)30252-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082895684"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-05", 
    "datePublishedReg": "2011-05-01", 
    "description": "BACKGROUND: An increasing proportion of patients with acute coronary syndrome (ACS) requiring percutaneous coronary intervention (PCI) are classified as elderly (aged \u226570 years). The glycoprotein IIb/IIIa inhibitor abciximab is known to reduce adverse outcomes in patients aged <70 years with high-risk ACS undergoing PCI, but conflicting findings relating to its effects in the elderly have been reported.\nOBJECTIVE: The aim of this study was to evaluate the effect of abciximab in elderly high-risk ACS patients undergoing PCI.\nMETHODS: From our dedicated PCI registry we identified 2068 ACS patients with high-risk lesions that were treated with PCI. Baseline data were collected prospectively. All-cause mortality, target vessel revascularization (TVR), myocardial infarction (MI), and the combination of these were primary study endpoints. All endpoints within 1 year after PCI were registered and validated. The population was subsequently stratified according to age and use of abciximab.\nRESULTS: Elderly patients constituted 42% of the total population. They presented with more co-morbidities, were less frequently treated with abciximab and had a higher risk of reaching the combined endpoint and higher all-cause mortality than younger patients. The age/abciximab stratified analysis revealed no effect of abciximab on any of the endpoints in elderly patients (combined endpoint: no abciximab 22.6% vs abciximab 23.4%, p=0.85; all-cause mortality: no abciximab 15.4% vs abciximab 15.9%, p=0.91; TVR: no abciximab 3.4% vs abciximab 5.5%, p=0.21; MI: no abciximab 7.0% vs abciximab 8.5%, p=0.54), whereas all-cause mortality and the risk of reaching the combined endpoint were significantly reduced in younger patients (combined endpoint: no abciximab 14.0% vs abciximab 9.4%, p=0.03; all-cause mortality: no abciximab 4.5% vs abciximab 1.7%, p=0.02; TVR: no abciximab 5.5% vs abciximab 4.3%, p=0.39; MI: no abciximab 7.2% vs abciximab 6.6%, p=0.80). These findings were confirmed in our adjusted analyses.\nCONCLUSIONS: In this large observational study we found no benefit of abciximab treatment in elderly high-risk ACS patients who underwent PCI. These findings should be taken into consideration when deciding on the treatment strategy for elderly ACS patients undergoing PCI.", 
    "genre": "research_article", 
    "id": "sg:pub.10.2165/11587170-000000000-00000", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100990", 
        "issn": [
          "1170-229X", 
          "1179-1969"
        ], 
        "name": "Drugs & Aging", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "name": "Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention", 
    "pagination": "369-378", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6a1db713468960e1ebe27070eed367d31f713a4071a04bfdb48b5de918da762a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21542659"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9102074"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/11587170-000000000-00000"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1022273563"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/11587170-000000000-00000", 
      "https://app.dimensions.ai/details/publication/pub.1022273563"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T22:37", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8690_00000536.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.2165%2F11587170-000000000-00000"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/11587170-000000000-00000'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/11587170-000000000-00000'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/11587170-000000000-00000'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/11587170-000000000-00000'


 

This table displays all metadata directly associated to this object as RDF triples.

240 TRIPLES      21 PREDICATES      71 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/11587170-000000000-00000 schema:about N2d9bcc3fd46347c4bfcebf5b68075b8a
2 N2fa5c60068504e00a1df092d04687318
3 N5a122611694b4ab1bc7c85b8b236dd7f
4 N6025094f58dd44c69fa1501b1b39907f
5 N6ad53a2a370845c59b2c823a453d16a5
6 N6e9d48b5621847c98bee038811f3e79b
7 N8998030dc3f34a1e9e848406358572fc
8 N8e5fdf163ffd42b4a333707319e483b0
9 N908736050d714f5ebc55e754959954fe
10 Na80a04f91182427aa20b852df05c422a
11 Nafc793bc4d9c4d50b15252f2ea099c29
12 Ncc6be387984840ffb340f509f073cd36
13 Nd53dd50a9717499ea162a169190bdb3b
14 anzsrc-for:11
15 anzsrc-for:1103
16 schema:author N2e34fdd8c7cd494c97d965422dcb7025
17 schema:citation sg:pub.10.2165/00002512-200016030-00003
18 https://app.dimensions.ai/details/publication/pub.1078321162
19 https://doi.org/10.1001/jama.286.6.708
20 https://doi.org/10.1001/jama.295.13.joc60034
21 https://doi.org/10.1002/ccd.20456
22 https://doi.org/10.1016/j.ahj.2004.06.003
23 https://doi.org/10.1016/j.ahj.2006.07.005
24 https://doi.org/10.1016/j.amjcard.2005.06.072
25 https://doi.org/10.1016/j.cardiores.2004.12.027
26 https://doi.org/10.1016/j.ijcard.2008.02.015
27 https://doi.org/10.1016/s0140-6736(96)10452-9
28 https://doi.org/10.1016/s0140-6736(98)06113-3
29 https://doi.org/10.1016/s0140-6736(98)85010-1
30 https://doi.org/10.1016/s0749-0690(18)30252-0
31 https://doi.org/10.1016/s0895-4356(02)00591-7
32 https://doi.org/10.1056/nejm199404073301402
33 https://doi.org/10.1056/nejm199706123362401
34 https://doi.org/10.1093/eurheartj/ehi731
35 https://doi.org/10.1093/eurheartj/ehp118
36 https://doi.org/10.1111/j.1076-7460.2000.80049.x
37 https://doi.org/10.1161/01.cir.0000142862.98817.1f
38 https://doi.org/10.1161/01.cir.103.25.3051
39 https://doi.org/10.1161/01.cir.78.2.486
40 https://doi.org/10.1161/01.cir.99.23.2986
41 https://doi.org/10.1161/01.hyp.38.2.274
42 https://doi.org/10.1161/circulationaha.106.642306
43 https://doi.org/10.1161/circulationaha.106.685313
44 https://doi.org/10.1161/circulationaha.107.182615
45 https://doi.org/10.7326/0003-4819-141-3-200408030-00007
46 schema:datePublished 2011-05
47 schema:datePublishedReg 2011-05-01
48 schema:description BACKGROUND: An increasing proportion of patients with acute coronary syndrome (ACS) requiring percutaneous coronary intervention (PCI) are classified as elderly (aged ≥70 years). The glycoprotein IIb/IIIa inhibitor abciximab is known to reduce adverse outcomes in patients aged <70 years with high-risk ACS undergoing PCI, but conflicting findings relating to its effects in the elderly have been reported. OBJECTIVE: The aim of this study was to evaluate the effect of abciximab in elderly high-risk ACS patients undergoing PCI. METHODS: From our dedicated PCI registry we identified 2068 ACS patients with high-risk lesions that were treated with PCI. Baseline data were collected prospectively. All-cause mortality, target vessel revascularization (TVR), myocardial infarction (MI), and the combination of these were primary study endpoints. All endpoints within 1 year after PCI were registered and validated. The population was subsequently stratified according to age and use of abciximab. RESULTS: Elderly patients constituted 42% of the total population. They presented with more co-morbidities, were less frequently treated with abciximab and had a higher risk of reaching the combined endpoint and higher all-cause mortality than younger patients. The age/abciximab stratified analysis revealed no effect of abciximab on any of the endpoints in elderly patients (combined endpoint: no abciximab 22.6% vs abciximab 23.4%, p=0.85; all-cause mortality: no abciximab 15.4% vs abciximab 15.9%, p=0.91; TVR: no abciximab 3.4% vs abciximab 5.5%, p=0.21; MI: no abciximab 7.0% vs abciximab 8.5%, p=0.54), whereas all-cause mortality and the risk of reaching the combined endpoint were significantly reduced in younger patients (combined endpoint: no abciximab 14.0% vs abciximab 9.4%, p=0.03; all-cause mortality: no abciximab 4.5% vs abciximab 1.7%, p=0.02; TVR: no abciximab 5.5% vs abciximab 4.3%, p=0.39; MI: no abciximab 7.2% vs abciximab 6.6%, p=0.80). These findings were confirmed in our adjusted analyses. CONCLUSIONS: In this large observational study we found no benefit of abciximab treatment in elderly high-risk ACS patients who underwent PCI. These findings should be taken into consideration when deciding on the treatment strategy for elderly ACS patients undergoing PCI.
49 schema:genre research_article
50 schema:inLanguage en
51 schema:isAccessibleForFree false
52 schema:isPartOf N9c07d258666a410fb1ac16e06b0a598c
53 Nf6872e60becf44beac5b7a73251469fb
54 sg:journal.1100990
55 schema:name Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
56 schema:pagination 369-378
57 schema:productId N4de9bb46a6d44229b70b8b657aa8ccb3
58 N5680400bca7a4f748f77f736da9ba1dd
59 Nca428067f6884f819917eeae67ba2dcf
60 Ncc31d7e2062345a5b7793f6f8fbc81f1
61 Nd9c290128ca242c9b4b7bad72b8727a6
62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022273563
63 https://doi.org/10.2165/11587170-000000000-00000
64 schema:sdDatePublished 2019-04-10T22:37
65 schema:sdLicense https://scigraph.springernature.com/explorer/license/
66 schema:sdPublisher Nbb830934524e4c17865df26884787528
67 schema:url http://link.springer.com/10.2165%2F11587170-000000000-00000
68 sgo:license sg:explorer/license/
69 sgo:sdDataset articles
70 rdf:type schema:ScholarlyArticle
71 N2c60d03092154d12a875578b890c62bd rdf:first sg:person.01212500565.03
72 rdf:rest N451b8c612d7a4ab5903049ce8c8a46bb
73 N2d9bcc3fd46347c4bfcebf5b68075b8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Registries
75 rdf:type schema:DefinedTerm
76 N2e34fdd8c7cd494c97d965422dcb7025 rdf:first sg:person.01114465002.35
77 rdf:rest Nd885deded5c04e9a95ee8fc93b36b045
78 N2fa5c60068504e00a1df092d04687318 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Endpoint Determination
80 rdf:type schema:DefinedTerm
81 N451b8c612d7a4ab5903049ce8c8a46bb rdf:first sg:person.01007016143.59
82 rdf:rest Ncb9a8a3af5d64fde9217a34d5d3abf02
83 N4de9bb46a6d44229b70b8b657aa8ccb3 schema:name dimensions_id
84 schema:value pub.1022273563
85 rdf:type schema:PropertyValue
86 N5680400bca7a4f748f77f736da9ba1dd schema:name readcube_id
87 schema:value 6a1db713468960e1ebe27070eed367d31f713a4071a04bfdb48b5de918da762a
88 rdf:type schema:PropertyValue
89 N5a122611694b4ab1bc7c85b8b236dd7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Middle Aged
91 rdf:type schema:DefinedTerm
92 N6025094f58dd44c69fa1501b1b39907f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Male
94 rdf:type schema:DefinedTerm
95 N6ad53a2a370845c59b2c823a453d16a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Angioplasty
97 rdf:type schema:DefinedTerm
98 N6e9d48b5621847c98bee038811f3e79b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Antibodies, Monoclonal
100 rdf:type schema:DefinedTerm
101 N8998030dc3f34a1e9e848406358572fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Aged
103 rdf:type schema:DefinedTerm
104 N8e5fdf163ffd42b4a333707319e483b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Risk
106 rdf:type schema:DefinedTerm
107 N908736050d714f5ebc55e754959954fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Humans
109 rdf:type schema:DefinedTerm
110 N9c07d258666a410fb1ac16e06b0a598c schema:issueNumber 5
111 rdf:type schema:PublicationIssue
112 Na80a04f91182427aa20b852df05c422a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Platelet Glycoprotein GPIIb-IIIa Complex
114 rdf:type schema:DefinedTerm
115 Nafc793bc4d9c4d50b15252f2ea099c29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Female
117 rdf:type schema:DefinedTerm
118 Nbb830934524e4c17865df26884787528 schema:name Springer Nature - SN SciGraph project
119 rdf:type schema:Organization
120 Nca428067f6884f819917eeae67ba2dcf schema:name pubmed_id
121 schema:value 21542659
122 rdf:type schema:PropertyValue
123 Ncb9a8a3af5d64fde9217a34d5d3abf02 rdf:first sg:person.012431026112.60
124 rdf:rest rdf:nil
125 Ncc31d7e2062345a5b7793f6f8fbc81f1 schema:name nlm_unique_id
126 schema:value 9102074
127 rdf:type schema:PropertyValue
128 Ncc6be387984840ffb340f509f073cd36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Immunoglobulin Fab Fragments
130 rdf:type schema:DefinedTerm
131 Nd53dd50a9717499ea162a169190bdb3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Acute Coronary Syndrome
133 rdf:type schema:DefinedTerm
134 Nd885deded5c04e9a95ee8fc93b36b045 rdf:first sg:person.01026574677.68
135 rdf:rest N2c60d03092154d12a875578b890c62bd
136 Nd9c290128ca242c9b4b7bad72b8727a6 schema:name doi
137 schema:value 10.2165/11587170-000000000-00000
138 rdf:type schema:PropertyValue
139 Nf6872e60becf44beac5b7a73251469fb schema:volumeNumber 28
140 rdf:type schema:PublicationVolume
141 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
142 schema:name Medical and Health Sciences
143 rdf:type schema:DefinedTerm
144 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
145 schema:name Clinical Sciences
146 rdf:type schema:DefinedTerm
147 sg:journal.1100990 schema:issn 1170-229X
148 1179-1969
149 schema:name Drugs & Aging
150 rdf:type schema:Periodical
151 sg:person.01007016143.59 schema:affiliation https://www.grid.ac/institutes/grid.411646.0
152 schema:familyName Madsen
153 schema:givenName Jan K.
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007016143.59
155 rdf:type schema:Person
156 sg:person.01026574677.68 schema:affiliation https://www.grid.ac/institutes/grid.411646.0
157 schema:familyName Galatius
158 schema:givenName Soeren
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026574677.68
160 rdf:type schema:Person
161 sg:person.01114465002.35 schema:affiliation https://www.grid.ac/institutes/grid.411646.0
162 schema:familyName Iversen
163 schema:givenName Allan Zeeberg
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114465002.35
165 rdf:type schema:Person
166 sg:person.01212500565.03 schema:affiliation https://www.grid.ac/institutes/grid.411646.0
167 schema:familyName Pedersen
168 schema:givenName Sune
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212500565.03
170 rdf:type schema:Person
171 sg:person.012431026112.60 schema:affiliation https://www.grid.ac/institutes/grid.5254.6
172 schema:familyName Jensen
173 schema:givenName Jan S.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012431026112.60
175 rdf:type schema:Person
176 sg:pub.10.2165/00002512-200016030-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026921696
177 https://doi.org/10.2165/00002512-200016030-00003
178 rdf:type schema:CreativeWork
179 https://app.dimensions.ai/details/publication/pub.1078321162 schema:CreativeWork
180 https://doi.org/10.1001/jama.286.6.708 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046042299
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1001/jama.295.13.joc60034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039342754
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1002/ccd.20456 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013928798
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/j.ahj.2004.06.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009659065
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/j.ahj.2006.07.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038467272
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/j.amjcard.2005.06.072 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015979769
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/j.cardiores.2004.12.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001812022
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/j.ijcard.2008.02.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036705033
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/s0140-6736(96)10452-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044275166
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/s0140-6736(98)06113-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054617046
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/s0140-6736(98)85010-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044923927
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/s0749-0690(18)30252-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082895684
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/s0895-4356(02)00591-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033511300
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1056/nejm199404073301402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040255966
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1056/nejm199706123362401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017752478
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1093/eurheartj/ehi731 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034540833
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1093/eurheartj/ehp118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031010310
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1111/j.1076-7460.2000.80049.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1047924281
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1161/01.cir.0000142862.98817.1f schema:sameAs https://app.dimensions.ai/details/publication/pub.1035757918
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1161/01.cir.103.25.3051 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002347157
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1161/01.cir.78.2.486 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001424008
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1161/01.cir.99.23.2986 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045165937
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1161/01.hyp.38.2.274 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041862010
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1161/circulationaha.106.642306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007883017
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1161/circulationaha.106.685313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052751505
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1161/circulationaha.107.182615 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003775013
231 rdf:type schema:CreativeWork
232 https://doi.org/10.7326/0003-4819-141-3-200408030-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073707555
233 rdf:type schema:CreativeWork
234 https://www.grid.ac/institutes/grid.411646.0 schema:alternateName Gentofte Hospital
235 schema:name Department of Cardiology P, Gentofte University Hospital, Niels Andersens Vej 65, DK-2900, Hellerup, Denmark
236 rdf:type schema:Organization
237 https://www.grid.ac/institutes/grid.5254.6 schema:alternateName University of Copenhagen
238 schema:name Clinical Institute of Surgery and Internal Medicine, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark
239 Department of Cardiology P, Gentofte University Hospital, Niels Andersens Vej 65, DK-2900, Hellerup, Denmark
240 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...